Literature DB >> 3056246

Paradoxical antibacterial activities of beta-lactams against Proteus vulgaris: mechanism of the paradoxical effect.

Y Ikeda1, T Nishino.   

Abstract

Fifteen beta-lactam antibiotics were divided into four classes based on their antibacterial actions and beta-lactamase-inducing activities in Proteus vulgaris. One of these groups, which included cefmenoxime, ceftriaxone, cefuzonam, and cefotaxime, showed a clear paradoxical antibacterial activity against P. vulgaris. This group showed growth-inhibitory activity at relatively low concentrations, up to certain limits. These cephalosporins have, as a common moiety, an aminothiazolyl-oxyimino group in the 7-acyl side chain and have high beta-lactamase-inducing activities and low stabilities against the beta-lactamase. In a mutant strain incapable of inducing beta-lactamase, however, the paradoxical antibacterial activity was not observed. These findings suggest that beta-lactamase plays an essential role in the paradoxical antibacterial effect in P. vulgaris. We conclude that the induction of a large amount of beta-lactamase and the low stability against beta-lactamase may account for the paradoxical antibacterial activity in P. vulgaris.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3056246      PMCID: PMC172346          DOI: 10.1128/AAC.32.7.1073

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Penicillin-binding proteins and cell shape in E. coli.

Authors:  B G Spratt; A B Pardee
Journal:  Nature       Date:  1975-04-10       Impact factor: 49.962

2.  Micro-iodometric assay for penicillinase.

Authors:  R P NOVICK
Journal:  Biochem J       Date:  1962-05       Impact factor: 3.857

3.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

4.  Nalidixic acid: an antibacterial paradox.

Authors:  G C Crumplin; J T Smith
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

5.  A direct spectrophotometric assay and determination of Michaelis constants for the beta-lactamase reaction.

Authors:  A Samuni
Journal:  Anal Biochem       Date:  1975-01       Impact factor: 3.365

6.  Investigation of the beta-lactamase stability of ceftazidime and eight other new cephalosporin antibiotics.

Authors:  I N Simpson; S J Plested; P B Harper
Journal:  J Antimicrob Chemother       Date:  1982-05       Impact factor: 5.790

7.  Bacteriological study on effects of beta-lactam group antibiotics in high concentrations.

Authors:  T Nishino; S Nakazawa
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

8.  Induction of beta-lactamase in Proteus vulgaris.

Authors:  K Okonogi; M Kuno; E Higashide
Journal:  J Gen Microbiol       Date:  1986-01

9.  Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.

Authors:  K Okonogi; M Kuno; M Kida; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

10.  The purification and some properties of a beta-lactamase (cephalosporinase) synthesized by Enterobactercloacae.

Authors:  T D Hennessey; M H Richmond
Journal:  Biochem J       Date:  1968-09       Impact factor: 3.857

View more
  3 in total

1.  Paradoxical activity of beta-lactam antibiotics against Proteus vulgaris in experimental infection in mice.

Authors:  Y Ikeda; Y Fukuoka; K Motomura; T Yasuda; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

2.  Programming stress-induced altruistic death in engineered bacteria.

Authors:  Yu Tanouchi; Anand Pai; Nicolas E Buchler; Lingchong You
Journal:  Mol Syst Biol       Date:  2012       Impact factor: 11.429

3.  Synthesis and Evaluation of Troponoids as a New Class of Antibiotics.

Authors:  Feng Cao; Cari Orth; Maureen J Donlin; Patrick Adegboyega; Marvin J Meyers; Ryan P Murelli; Mohamed Elagawany; Bahaa Elgendy; John E Tavis
Journal:  ACS Omega       Date:  2018-11-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.